4-((1H-Imidazol-1-yl)methyl)piperidine

Catalog No.: 
ACANEH527
CAS No.: 
90748-03-1
Molecular Formula: 
C9H15N3
Molecular Weight: 
165.24
4-((1H-Imidazol-1-yl)methyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$324.00InquiryInquiry
250mg95%$613.00InquiryInquiry
1g95%$2403.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((1H-Imidazol-1-yl)methyl)piperidine
IUPAC Name4-((1H-imidazol-1-yl)methyl)piperidine
MDL No.MFCD09971171
Molecular FormulaC9H15N3
Molecular Weight165.24
SMILESC1(CN2C=CN=C2)CCNCC1
InChI KeyZPCQDEWEJQHOJX-UHFFFAOYSA-N
Synonym4-(1H-imidazol-1-ylmethyl)piperidine(SALTDATA: 2HCl);4-(1H-IMIDAZOL-1-YLMETHYL)-PIPERIDINE;4-[(1-Imidazolyl)methyl]piperidine;Piperidine, 4-(1H-imidazol-1-ylmethyl)-;4-(imidazol-1-ylmethyl)piperidine
CAS No.90748-03-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACANEH527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  6. Then
  7. ACANEH527 route product structure diagram
    ACANEH52790748-03-1
Inquiry

2. ACANEH527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACANEH527 route product structure diagram
    ACANEH52790748-03-1
Inquiry

3. ACANEH527 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACANEH527 route product structure diagram
    ACANEH52790748-03-1
Inquiry

Comments (0)